There’s an increasing amount value being created in Neuren, which, in my opinion, is not being translated to the share price.
I agree that $25 is a reasonable number if the next trial shows good safety and efficacy profile, but the sky is the limit if the following trial also has a similar result.
There’s an increasing amount value being created in Neuren,...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.91 |
Change
-0.280(1.46%) |
Mkt cap ! $2.418B | |||
| Open | High | Low | Value | Volume |
| $18.98 | $19.15 | $18.90 | $3.046M | 160.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 319 | $18.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.93 | 247 | 9 |
View Market Depth
| Last trade - 11.46am 02/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |